Stay up to date on recent advances in oncology nursing and patient care.
Subcutaneous Daratumumab Reduces Smoldering Myeloma Progression
Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies
Venetoclax Combo Did Not Increase OS in Intermediate/High-Risk MDS
Laura Zitella Discusses the Growing Arsenal of Bispecific Antibodies in DLBCL
How to Manage ICANS in Patients With Hematologic Cancers
Managing CRS in Hematologic Cancers: A Nursing Perspective
Safety Management With Amivantamab Plus Lazertinib in NSCLC
Tepotinib Shows Manageable Safety in MET Exon 14+ NSCLC
Adverse Events of Menin Inhibitors in AML: What Nurses Should Know
Ivonescimab/Chemo Ups PFS After Third-Generation TKI in EGFR+ NSCLC
